Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Ding

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Scientific Reports|May 8, 2021
Half-life modeling of basic fibroblast growth factor released from growth factor-eluting polyelectrolyte multilayersIvan Ding, Amy M Peterson
Cancer Research|August 18, 2004
Pathophysiological effects of vascular endothelial growth factor receptor-2-blocking antibody plus fractionated radiotherapy on murine mammary tumorsBruce M Fenton, Scott F Paoni, Ivan Ding
Advances in Experimental Medicine and Biology|February 13, 2003
Evidence for and against hypoxia as the primary cause of tumor aggressivenessPaul Okunieff, Ivan Ding, Peter Vaupel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 7, 2004
Effect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumorsBruce M Fenton, Scott F Paoni, Ivan Ding
Journal of Colloid and Interface Science|March 9, 2020
Impact of molecular weight on polyelectrolyte multilayer assembly and surface propertiesElizabeth G Towle, Ivan Ding, Amy M Peterson
Advances in Experimental Medicine and Biology|April 6, 2006
Varied response of spontaneous tumors to antiangiogenic agentsBruce M Fenton, Scott F Paoni, Brian Grimwood, et al.
Advances in Experimental Medicine and Biology|August 31, 2007
Intratumoral VEGF and FGF1 administration alters tumor growth, vascular density, oxygenation, and expression of MCP-1 and interleukinsPaul Okunieff, Jianzhong Sun, Bruce Fenton, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|June 14, 2002
Comparison and modulation of angiogenic responses by FGFs, VEGF and SCF in murine and human fibrosarcomasIvan Ding, Weimin Liu, Jianzhong Sun, et al.
Advances in Experimental Medicine and Biology|June 4, 2004
A new intrinsic hypoxia marker in esophageal cancerIvan Ding, Paul Okunieff, Konstantin Salnikow, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Disparate effects of endostatin on tumor vascular perfusion and hypoxia in two murine mammary carcinomasBruce M Fenton, Scott F Paoni, Brian G Grimwood, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Scientific Reports|May 8, 2021
Half-life modeling of basic fibroblast growth factor released from growth factor-eluting polyelectrolyte multilayersIvan Ding, Amy M Peterson
Cancer Research|August 18, 2004
Pathophysiological effects of vascular endothelial growth factor receptor-2-blocking antibody plus fractionated radiotherapy on murine mammary tumorsBruce M Fenton, Scott F Paoni, Ivan Ding
Advances in Experimental Medicine and Biology|February 13, 2003
Evidence for and against hypoxia as the primary cause of tumor aggressivenessPaul Okunieff, Ivan Ding, Peter Vaupel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 7, 2004
Effect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumorsBruce M Fenton, Scott F Paoni, Ivan Ding
Journal of Colloid and Interface Science|March 9, 2020
Impact of molecular weight on polyelectrolyte multilayer assembly and surface propertiesElizabeth G Towle, Ivan Ding, Amy M Peterson
Advances in Experimental Medicine and Biology|April 6, 2006
Varied response of spontaneous tumors to antiangiogenic agentsBruce M Fenton, Scott F Paoni, Brian Grimwood, et al.
Advances in Experimental Medicine and Biology|August 31, 2007
Intratumoral VEGF and FGF1 administration alters tumor growth, vascular density, oxygenation, and expression of MCP-1 and interleukinsPaul Okunieff, Jianzhong Sun, Bruce Fenton, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|June 14, 2002
Comparison and modulation of angiogenic responses by FGFs, VEGF and SCF in murine and human fibrosarcomasIvan Ding, Weimin Liu, Jianzhong Sun, et al.
Advances in Experimental Medicine and Biology|June 4, 2004
A new intrinsic hypoxia marker in esophageal cancerIvan Ding, Paul Okunieff, Konstantin Salnikow, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Disparate effects of endostatin on tumor vascular perfusion and hypoxia in two murine mammary carcinomasBruce M Fenton, Scott F Paoni, Brian G Grimwood, et al.
Pageof 4